Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FL1T5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,062
Award facts
- Contract value 100% obligated
- $123,062.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $123,062.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, was awarded without a set-aside designation. DMS Pharmaceutical Group is performing under its larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
As a specialized oncology pharmaceutical supplier to federal agencies since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to compete in DLA pharmaceutical procurement markets. Keytruda, an immunotherapy cancer treatment, is among the specialized medications the company regularly delivers to Department of Defense healthcare sites. The delivery order represents a routine procurement under the company's established IDC vehicle, enabling the DLA to efficiently source branded pharmaceuticals and biologics required by military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FL1T5?
SPE2DB25FL1T5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FL1T5 worth?
The government has obligated $123,062 on SPE2DB25FL1T5.
Is contract SPE2DB25FL1T5 an order under another contract?
Yes. SPE2DB25FL1T5 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1T5 competed?
The extent of competition for SPE2DB25FL1T5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award